GCAN 8-K
Trafalgar International, Inc. (GCAN)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)
(Exact Name of Registrant as Specified in Charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of Principal Executive Offices)
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| None | GCAN | None |
As used in this Current Report on Form 8-K (this “Current Report”), and unless otherwise indicated, the terms “the Company,” “GCAN,” “we,” “us” and “our” refer to The Greater Cannabis Company, Inc. and its subsidiaries.
| Item 4.01 | Changes in Registrant’s Certifying Accountant. |
| (a) | Olayinka Oyebola & Co. |
(i) On March 6, 2025, the Company ended the engagement of Olayinka Oyebola & Co. (“Olayinka”) as GCAN’s independent registered public accounting firm. The decision to end the engagement of Olayinka Oyebola & Co. was approved by unanimous written consent of the Company’s board of directors on March 5, 2025.
(ii) The reports of Olayinka on the Company’s consolidated financial statements for the year ended December 31, 2023, did not contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles, except that such reports on the Company’s consolidated financial statements contained an explanatory paragraph in respect to the substantial doubt about its ability to continue as a going concern.
(iii) During the Company’s most recent fiscal year ended December 31, 2023, and the subsequent interim period through the date of this Current Report, (a) there have been no disagreements with Olayinka whether or not resolved, on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to the satisfaction of Olayinka, would have caused Olayinka to make reference to the subject matter of the disagreement in connection with its reports; (b) no such disagreement was discussed with our board of directors as a whole; and (d) there have been no “reportable events” as defined in Item 304(a)(1)(v) of Regulation S-K.
(iv) Olayinka has provided us with a letter addressed to the Securities and Exchange Commission (the “SEC”) stating it agrees with the statements in part (a) of Item 4.01 of this Current Report. A copy of the letter is filed concurrently herewith as Exhibit 16.1.
| (b) | Engagement of Aloba Awomolo & Partners (AAP) |
(i) Effective March 6, 2025, GCAN engaged Aloba Awomolo & Partners (“AAP”) as its independent public registered accounting firm. The engagement of AAP was approved by the unanimous written consent of the Company’s board of directors on March 5, 2025.
(ii) During the Company’s two most recent fiscal years ended December 31, 2023 and December 31, 2022, and the subsequent interim period through the date of this Current Report, we did not consult with AAP regarding either (a) the application of accounting principles to any specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on our financial statements; or (b) any matter that was either the subject of a disagreement or a “reportable event” as defined in Item 304(a)(1)(iv) and (v) of Regulation S-K.
| Item 9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits |
| Exhibit No | Description | |
| 16.1 | Olayinka Oyebola & Co. | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| The
Greater Cannabis Company, Inc. a Florida corporation | ||
| Dated: March 6, 2025 | By: | /s/ Aitan Zacharin |
| Chief Executive Officer | ||
Exhibit 16.1
March 6, 2024
United States Securities and Exchange
Commission Office of the Chief Accountant
100 F Street, N.E.
Washington, D.C.
20549
Re: The Greater Cannabis Company, Inc.
Dear Sirs/Madams,
We have read the statements under item 4.01 in the Form 8-K dated March 5, 2025, of The Greater Cannabis Company, Inc. to be filed with the Securities and Exchange Commission and we agree with such statements therein as related to our firm.
Regards,
Yours faithfully,
For: Olayinka Oyebola & Co
Yinka Oyebola FCA
Managing Partner/CEO